Table 1.
Characteristics | Overall | Mono therapy | dual therapy | > 3 drugtherapy | P value* |
---|---|---|---|---|---|
%(n) N = 1132** |
%(n) 41.2(491) |
%(n) 32.2(384) |
%(n) 14.8(176) |
||
Age(years) mean (SD) |
62.5(12.47) | 62.8(12.3) | 62.2(12.4) | 62.5(12.6) | 0.75 |
Age groups(years) 18-39 |
3.3(39) | 43.6(17) | 28.2(11) | 28.2(11) | |
40-59 | 33.8(402) | 39.1(157) | 36.3(146) | 24.6(99) | |
≥60 | 62.8(748) | 42.2(316) | 30.3(227) | 27.4(205) | 0.33 |
Gender males |
45.3(540) | 42.1(216) | 32.4(166) | 29.3(158) | 0.14 |
Comorbids conditions | |||||
Diabetes | 46.3(551) | 41.2(219) | 34.0(181) | 27.4(151) | 0.62 |
Chronic kidney disease | 8.9(106) | 34.6(36) | 38.5(40) | 28.3(30) | 0.25 |
Ischemic heart disease | 34.9(416) | 33.6(137) | 36.3(148) | 31.5(131) | < 0.001 |
Stroke | 11.6(138) | 41.4(55) | 36.1(48) | 25.4(35) | 0.9 |
Chronic liver disease | 4.7(56) | 41.8(23) | 34.5(19) | 25(14) | 0.91 |
Systolic Blood pressure mean (SD) |
136.2(25) | 136.2(23.98) | 135.6(25.05) | 136.8(27.2) | 0.8 |
Diastolic blood Pressure mean (SD) |
77.66(14) | 77.7(12.90) | 77.4(14.28) | 77.7(16.5) | 0.9 |
*p value < 0.05 is significant; it is for the groups(monotherapy,2 drug therapy and ≥3 drug therapy)
**59 patients had missing records for comorbids